SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Medical (VSAR)

Strong close

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BrandonLJ Member Profile
 
Followed By 3
Posts 240
Boards Moderated 0
Alias Born 09/20/17
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/4/2017 4:45:22 PM
Report: Exploring Fundamental Drivers Behind Amerco, Caesars Entertainment, Air Products and Chemicals, Consolidated Edison, ... "GlobeNewswire Inc." - 11/30/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/22/2017 5:06:53 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2017 4:04:45 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/26/2017 4:25:53 PM
Versartis Reports Third Quarter 2017 Financial Results and Provides Corporate Update "GlobeNewswire Inc." - 10/26/2017 4:05:00 PM
Versartis Hires Cowen to Assist in Evaluating Potential Strategic Transactions "GlobeNewswire Inc." - 10/26/2017 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/23/2017 5:03:33 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/23/2017 5:02:41 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/23/2017 5:01:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/23/2017 4:59:35 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/11/2017 5:24:59 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 10/10/2017 8:56:10 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/26/2017 5:13:28 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/25/2017 4:08:49 PM
Versartis Announces Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone Deficiency Did Not Meet Primary Endpoin... "GlobeNewswire Inc." - 9/21/2017 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/12/2017 5:02:43 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 9/12/2017 6:01:34 AM
Versartis’ Twice-Monthly Somavaratan for Pediatric Growth Hormone Deficiency to be Featured in Oral and Poster Presentation... "GlobeNewswire Inc." - 9/7/2017 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/6/2017 6:14:47 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/6/2017 6:13:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/6/2017 4:39:37 PM
Versartis Announces Expansion of Executive Leadership Team with Addition of Dr. Robert Gut as the Head of Global Clinical, M... "GlobeNewswire Inc." - 9/5/2017 4:05:00 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 8/31/2017 3:39:58 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 8/14/2017 4:57:21 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist